Notice2026-10353
National Cancer Institute; Notice of Meeting
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
May 26, 2026
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Full Text
<html>
<head>
<title>Federal Register, Volume 91 Issue 100 (Tuesday, May 26, 2026)</title>
</head>
<body><pre>
[Federal Register Volume 91, Number 100 (Tuesday, May 26, 2026)]
[Notices]
[Page 30664]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2026-10353]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the National Cancer
Institute Clinical Trials and Translational Research Advisory
Committee.
This will be a virtual meeting and will be open to the public as
indicated below. Individuals who plan to attend the virtual meeting and
need special assistance or other reasonable accommodations, should
notify the Contact Person listed below in advance of the meeting. The
meeting can be accessed from the NIH Videocast at the following link:
<a href="https://videocast.nih.gov/">https://videocast.nih.gov/</a>.
Name of Committee: National Cancer Institute Clinical Trials and
Translational Research Advisory Committee.
Date: July 15, 2026.
Time: 12:00 p.m. to 3:30 p.m.
Agenda: Discussion of NCI's Clinical and Translational Research
Programs.
Address: National Cancer Institute, 9609 Medical Center Dr.,
Rockville, MD 20850.
Meeting Format: Virtual Meeting.
Contact Person: Sheila A. Prindiville, M.D., M.P.H., Director,
Coordinating Center for Clinical Trials, National Cancer Institute,
National Institutes of Health, 9609 Medical Center Drive, Room
6W136, Rockville, MD 20850, 240-276-6173, <a href="/cdn-cgi/l/email-protection#dbaba9b2b5bfb2ada89bb6bab2b7f5b5b2b3f5bcb4ad"><span class="__cf_email__" data-cfemail="5424263d3a303d22271439353d387a3a3d3c7a333b22">[email protected]</span></a>.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
Information is also available on the Institute's/Center's home
page: <a href="http://deainfo.nci.nih.gov/advisory/ctac/ctac.htm">http://deainfo.nci.nih.gov/advisory/ctac/ctac.htm</a>, where an
agenda and any additional information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: May 20, 2026.
Bruce A. George,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2026-10353 Filed 5-22-26; 8:45 am]
BILLING CODE 4167-05-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on May 26, 2026.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.